1. Chemical and biological characterization of the DPP-IV inhibitory activity exerted by lupin (Lupinus angustifolius) peptides: From the bench to the bedside investigation
- Author
-
Universidad de Sevilla. Departamento de Bioquímica Médica y Biología Molecular e Inmunología, Instituto de Biomedicina de Sevilla (IBIS), Consejeria de Salud, Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades, Junta de Andalucia, Erasmus+ Mobility Programme, Ministerio de Economia y Competitividad, Gobierno de Espana, Ministerio de Educacion, Cultura y Deporte, Gobierno de Espana, PAIDI Program from Junta de Andalucia, Universidad de Sevilla, Cruz-Chamorro, Ivan, Santos-Sanchez, Guillermo, Bollati, Carlotta, Bartolomei, Martina, Capriotti, Anna Laura, Cerrato, Andrea, Millán-Linares, María del Carmen, Carrillo Vico, Antonio, Lammi, Carmen, Universidad de Sevilla. Departamento de Bioquímica Médica y Biología Molecular e Inmunología, Instituto de Biomedicina de Sevilla (IBIS), Consejeria de Salud, Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades, Junta de Andalucia, Erasmus+ Mobility Programme, Ministerio de Economia y Competitividad, Gobierno de Espana, Ministerio de Educacion, Cultura y Deporte, Gobierno de Espana, PAIDI Program from Junta de Andalucia, Universidad de Sevilla, Cruz-Chamorro, Ivan, Santos-Sanchez, Guillermo, Bollati, Carlotta, Bartolomei, Martina, Capriotti, Anna Laura, Cerrato, Andrea, Millán-Linares, María del Carmen, Carrillo Vico, Antonio, and Lammi, Carmen
- Abstract
Dipeptidyl peptidase IV (DPP-IV) is considered a key target for the diabetes treatment, since it is involved in glucose metabolism. Although lupin protein consumption shown hypoglycemic activity, there is no evidence of its effect on DPP-IV activity. This study demonstrates that a lupin protein hydrolysate (LPH), obtained by hydrolysis with Alcalase, exerts anti-diabetic activity by modulating DPP-IV activity. In fact, LPH decreased DPP-IV activity in a cell-free and cell-based system. Contextually, Caco-2 cells were employed to identify LPH peptides that can be intestinally trans-epithelial transported. Notably, 141 different intestinally transported LPH sequences were identified using nano- and ultra-chromatography coupled to mass spectrometry. Hence, it was demonstrated that LPH modulated the glycemic response and the glucose concentration in mice, by inhibiting the DPP-IV. Finally, a beverage containing 1 g of LPH decreased DPP-IV activity and glucose levels in humans.
- Published
- 2023